Investing Profile

Kostas Alevizopoulos

CEO
Partner at Ventac Partners
Photo of Kostas Alevizopoulos, Partner at Ventac Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Ventac Partners Network
14 CONNECTIONS
cb
$100K - $5.0M
$1.5M
Chief Executive Officer APIM TherapeuticsPresent
Partner Ventac PartnersPresent
Chief Executive Officer Medexis SAPresent
Strategic Advisor Exogenus TherapeuticsPresent
Scientific Advisor Foltene Laboratories SrlPresent
Chief Scientific Advisor Gerolymatos International SAPresent
Vice President & Board Member Hellenic Biotechnology ClusterPresent
Chief Scientific Officer PNG Gerolymatos SAPresent
Head of R & D Apotech CorporationPresent
Research Project Manager Swiss Inst. for Cancer Res. & Schering-Plough Res. InstitutePresent
Ethnikon kai Kapodistriakon Panepistimion Athinon Diploma in Biochemistry Biology
University of Lausanne - UNIL Ph.D. Molecular Biology
Sign in with Google →
Sign in with Google →